Zifan Zeng
- Molecular Biology
- Cardiology and Cardiovascular Medicine
- Pulmonary and Respiratory Medicine
- Cancer Research
- Oncology
- Topics
- Ferroptosis and cancer prognosis (8 papers)Cancer Immunotherapy and Biomarkers (4 papers)Cardiac Fibrosis and Remodeling (4 papers)
- Cited by
- Complementary and alternative medicineCancer ResearchCardiology and Cardiovascular Medicine
- Journals
- Journal of the American College of CardiologyInternational Journal of Radiation Oncology*Biology*PhysicsFrontiers in Immunology
- Partner nations
- ChinaUnited States
In The Last Decade
Zifan Zeng
24 papers receiving 360 citations
Peers
Comparison fields: 5 of 76
- Molecular Biology 189
- Cardiology and Cardiovascular Medicine 94
- Pulmonary and Respiratory Medicine 67
- Cancer Research 66
- Oncology 59
Countries citing papers authored by Zifan Zeng
This map shows the geographic impact of Zifan Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zifan Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zifan Zeng more than expected).
Fields of papers citing papers by Zifan Zeng
This network shows the impact of papers produced by Zifan Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zifan Zeng. The network helps show where Zifan Zeng may publish in the future.
Co-authorship network of co-authors of Zifan Zeng
This figure shows the co-authorship network connecting the top 25 collaborators of Zifan Zeng. A scholar is included among the top collaborators of Zifan Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zifan Zeng. Zifan Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 2 | |
| 5 | 2 | |
| 6 | 6 | |
| 7 | 13 | |
| 8 | 16 | |
| 9 | 53 | |
| 10 | 11 | |
| 11 | 2 | |
| 12 | 15 | |
| 13 | 18 | |
| 14 | 3 | |
| 15 | 91 | |
| 16 | 51 | |
| 17 | 2 | |
| 18 | 20 | |
| 19 | 20 | |
| 20 | Predicting coronary heart disease deaths in Beijing in 2010: Potential effects of risk factor trends | 1 |
About Zifan Zeng
Zifan Zeng is a scholar working on Aging, Biological Psychiatry and Cancer Research, having authored 25 papers that have together received 362 indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (8 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Cardiac Fibrosis and Remodeling (4 papers). The work is most often cited by research in Complementary and alternative medicine (43 citations), Cancer Research (66 citations) and Cardiology and Cardiovascular Medicine (94 citations). Zifan Zeng has collaborated with scholars based in China and United States. Frequent co-authors include Wenqiang Gan, Silin Lv, Min Yang, Yan Zheng, Rixin Zhang, Tiegang Li, Qiyan Wang, Chun Li, Wei Wang and Dongqing Guo. Their work appears in journals such as Journal of the American College of Cardiology, International Journal of Radiation Oncology*Biology*Physics and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.